Clinical utility of a novel perioperative quality assessment metric, trifecta, for radical cystectomy
Mahito Atsuta(Jikei University Kashiwa hospital), Jun Miki(Jikei University School of Medicine), Naoki Uchida(SHOWA Medical University), Naoya Tomomasa(Fuji Heavy Industries Health Insurance Society Ota Memorial Hospital), Wataru Fukuokaya(Jikei University School of Medicine), Shun Saito(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Masataka Kubo(Jikei University School of Medicine), Shunsuke Tsuzuki(Jikei University School of Medicine), Kazuhiro Takahashi, Takahiro Kimura(Jikei University School of Medicine), Hirokazu Kagawa(Jikei University School of Medicine), Takayuki Sano, Kosuke Iwatani(Jikei University Kashiwa hospital), Fumihiko Urabe(Jikei University School of Medicine)
Cited by 2
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel
|Journal of Biological Chemistry|2002|172